Insider buying last 90 days
No open-market insider purchases were filed for LRCX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Lam Research's shares moved this week on a mix of record financial results and emerging operational concerns. The company reported record fiscal first-quarter revenue and adjusted EPS, with operating margin exceeding 40% for the first time, driven by AI-fueled semiconductor demand, and calendar 2026 systems revenue is expected to grow over 40% year-on-year. Shares fell 4.14% on 2 November amid supply constraints, moderating sales guidance from China, executive stock sales, and institutional profit-taking, even as shareholders backed the board and pay plan at the annual meeting. The stock also saw continued insider share sales via Form 4 filings during the period.
LRCX closed at $221.43, down 4% from the prior close, with the price sitting below both its 50-day average of $289.28 and 200-day average of $284.33. Over the past month the stock has declined 33.7%, extending a three-month drop of 27.6%, though it remains up 37.3% over the past year. The GekkoIndex reads 69.8, placing the stock in the Accumulation zone. The price sits 18.2% below Gekko Fair Value of $270.81.
The next earnings report is scheduled for 27 January 2027, after close, placing it outside the typical 20-trading-day window. Smart money activity over the last 90 days shows 1 Congressional buy and 0 sells, alongside holdings from 3 billionaire investors and 5 trailblazer holders. Seasonality data show the next 20 trading days have averaged a 7.7% gain over the past 5 years, rising in 5 of those years. Analyst consensus among 23 firms stands at 21 buy and 2 hold ratings, with a consensus target of $364.03.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Lam Research scores 5 supportive, 1 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive1 mixed0 headwinds
Averages disagree
Close $221.43 sits between the 50-day ($289.28) and 200-day ($284.33) averages, or the averages disagree.
See the chart69.8, Accumulation
Reading 69.8 is in the Accumulation zone.
See the GekkoIndex18.2% below
Price is 18.2% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: Congress 1 buy / 0 sales.
See smart moneyReports in 83 days
Next report Jan 27, 2027, 83 days away — outside a typical 20-trading-day hold.
See earnings+7.7% on average
From this point in the calendar, the next 20 trading days averaged +7.7% over 5 years, rising in 5 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Lam Research closed at $221.43 on Nov 4, 2026, +37.3% over the past year, inside a 52-week range of $135.50 to $438.50.
Use the left and right arrow keys to read daily values.
Put LRCX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Lam Research makes the machines that chipmakers use to build integrated circuits, covering everything from design and manufacturing to sales, repair, and maintenance of that equipment. It is best known for its wide range of deposition and etching tools, sold under names such as ALTUS, SABRE, VECTOR, and Striker for depositing films, and Flex, Kiyo, Syndion, and Versys for etching processes. Its catalog also includes wafer cleaning systems like Da Vinci and EOS, bevel cleaning tools such as Coronus, and Metryx systems for measuring wafer mass during production.
The company's business centers on supplying this equipment and related services to semiconductor manufacturers worldwide, reaching customers across the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and other markets.
Lam Research was founded in 1980 and is headquartered in Fremont, California. Its shares are listed on the NASDAQ under the ticker LRCX.
Lam Research’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.8, in the Accumulation zone, up 3.1 points over five sessions.
Up 3.1 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 17 | +6.8% | +11.0% | ||
| Accumulation (current zone) | 160 | +0.8% | +4.5% | ||
| Neutral | 439 | +0.9% | +4.2% | ||
| Distribution | 77 | +1.7% | +4.5% | ||
| Selling | 4 | Too few readings yet | |||
Average LRCX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Lam Research trades 18.2% below Gekko Fair Value of $270.81, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Lam Research shares are worth, recalculated every trading day.
$270.81
Gekko Fair Value, Nov 4, 2026
18.2% Undervalued
At the end of Aug 2026 the price was 26.2% above the estimate.
No open-market insider purchases were filed for Lam Research, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for LRCX in the last 90 days.
From Form 4 filings, dated to when each was filed.
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| David Taylor House, OH, purchase | $1,001 - $15,000 | Oct 30 traded Oct 15 |
From congressional disclosures, which report amounts as ranges.
Lam Research has been buying back its own shares.
From company filings.
8of the funds Gekko tracks hold LRCX.
Lam Research reports on Jan 27, 2027, after the close (83 days away), and beat the EPS estimate in 8 of its last 8 reports.
Jan 27, 2027
Expected after the close, 83 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 21, 2026 | $2.20 est $2.18 | $8.22B est $8.14B | −12.6% |
| Jul 29, 2026 | $1.82 est $1.69 | $6.72B est $6.66B | +10.4% |
| Apr 22, 2026 | $1.47 est $1.35 | $5.84B est $5.75B | +0.1% |
| Jan 28, 2026 | $1.27 est $1.17 | $5.34B est $5.23B | +4.1% |
| Oct 22, 2025 | $1.26 est $1.22 | $5.32B est $5.22B | +1.7% |
| Jul 30, 2025 | $1.33 est $1.21 | $5.17B est $5.00B | −4.1% |
| Apr 23, 2025 | $1.04 est $1.00 | $4.72B est $4.64B | +11.7% |
| Jan 29, 2025 | $0.91 est $0.88 | $4.38B est $4.32B | +8.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Lam Research is $364.03, +64.4% from the last close, from 23 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 23 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 2 | Bernstein | $350 | +58.1% |
| Oct 25 | Bernstein | $350 | +58.1% |
| Oct 23 | DBS | $416 | +87.9% |
| Oct 22 | Stifel Nicolaus | $425 | +91.9% |
| Oct 22 | KeyBanc | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Lam Research averaged +7.7% across the last 5 years, rising in 5 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +7.0% | 5 of 5 |
| Next 10 trading days | +2.5% | 3 of 5 |
| Next 15 trading days | +4.8% | 3 of 5 |
| Next 20 trading days | +7.7% | 5 of 5 |
| Next 30 trading days | +8.4% | 4 of 5 |
For scale, LRCX’s typical 20-trading-day move in either direction is about 8.4%.
Lam Research’s market cap is $277.1B, with a P/E ratio of 33.9 and revenue of $26.13B over the last twelve months.
Coverage of Lam Research this week reads neutral: 3 positive, 11 neutral and 4 negative headlines.
Lam Research’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AMATApplied Materials | Accumulation | 29.1% below |
| PHParker-Hannifin | Accumulation | 2.4% below |
| TTTrane Technologies | Accumulation | 3.3% above |
| JCIJohnson Controls International | Accumulation | 6.8% above |
| CARRCarrier Global | Neutral | 0.0% above |
| IRIngersoll Rand | Neutral | 16.8% above |
A peer links to its own page where one exists.
Lam Research’s market cap is $277.1B at the Nov 4, 2026 close of $221.43, with 1.25B shares outstanding. The shares trade on a P/E ratio of 33.9.
The consensus analyst 12-month price target for Lam Research is $364.03, +64.4% from the last close. Of the 23 firms that rated the stock in the last 90 days, 21 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Lam Research is undervalued: the Nov 4, 2026 close of $221.43 is 18.2% below Gekko Fair Value of $270.81. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Lam Research is expected to report on Jan 27, 2027, after the market closes (83 days away). Analysts expect earnings of $2.34 per share on revenue of $8.63B. Lam Research beat the earnings estimate in 8 of its last 8 reports, moving 6.6% on average across the report.
Lam Research’s 52-week high is $438.50 and its 52-week low is $135.50; it closed at $221.43 on Nov 4, 2026, +37.3% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (gekkoindex, fair value, smart money, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,460 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.